Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
暂无分享，去创建一个
S. Libutti | P. Wingfield | R. Shoemaker | J. Penninger | R. Panettieri | Gerald Wirnsberger | H. Hochster | A. Hladik | S. Knapp | D. Mccormick | P. Starkl | N. Watts | D. Boring | S. Höller | J. Boone | R. Gawish | R. Matthews | J. Marshall | J. White | L. Pimenov | Quentin Lawrence | Brian D. Cholewa | J. Richig | Ben T. Chen | Romana Gugensberger